Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis

Arthritis & Rheumatism

Volumn 33, Issue 11, 1990, Pages 1611-1619

  Fries, James F ^a   Singh, Gurkirpal ^a   Lenert, Leslie ^a   Furst, Daniel E ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AURANOFIN; GOLD; HYDROXYCHLOROQUINE; INDOMETACIN; METHOTREXATE; NAPROXEN; PENICILLAMINE; PIROXICAM; PREDNISONE; SULINDAC; TOLMETIN;

ARTICLE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER TOXICITY; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ALANINE TRANSAMINASE; ANALYSIS OF VARIANCE; ARTHRITIS, RHEUMATOID; ASPARTATE AMINOTRANSFERASES; ASPIRIN; CANADA; COMPARATIVE STUDY; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMAN; HYDROXYCHLOROQUINE; LIVER; METHOTREXATE; PRODUCT SURVEILLANCE, POSTMARKETING; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; UNITED STATES;

EID: 0025678922     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780331102     Document Type: Article

References (36)

1. Methotrexate in rheumatoid arthritis.
2. Gold sodium thiomalate compared to low dose methotrexate in the treatment of rheumatoid arthritis: a randomized, double blind 26‐week trial.
3. Liver histology in rheumatoid arthritis patients receiving long‐term methotrexate therapy: a prospective study with baseline and sequential biopsy samples.
4. Long‐term prospective trial of low‐dose methotrexate in rheumatoid arthritis.
5. A long‐term prospective study of the use of methotrexate in rheumatoid arthritis: update after a mean of fifty‐three months.
6. Pulse methotrexate therapy in rheumatoid arthritis.
7. Efficacy of low‐dose methotrexate in rheumatoid arthritis.
8. Low‐dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis: a twenty‐four‐week controlled clinical trial.
9. The safety and efficacy of the use of methotrexate in long‐term therapy for rheumatoid arthritis.
10. Methotrexate in rheumatoid arthritis: indications, contraindications, efficacy, and safety.
11. Health and Public Policy Committee, American College of Physicians: Methotrexate in rheumatoid arthritis.
12. Methotrexate in rheumatoid arthritis: toxic effects as the major factor in limiting long‐term treatment.
13. Methotrexate‐induced liver abnormalities in rheumatoid arthritis.
14. The ARAMIS (American Rheumatism Association Medical Information System) post‐marketing surveillance program.
15. Measurement of patient outcome in arthritis.
16. Toward an understanding of patient outcome measurement.
17. A multicenter study of annual health service utilization and costs in rheumatoid arthritis.
18. Impact of specific therapy upon rheumatoid arthritis.
19. Disability in rheumatoid arthritis: comparison of prognostic factors across three populations.
20. The effect of organic acids on the renal clearance of methotrexate in man.
21. Nonlinear renal elimination kinetics of methotrexate due to saturation of renal tubular reabsorption.
22. Pharmacokinetics of low‐dose methotrexate in rheumatoid arthritis patients.
23. Pharmacologic actions of 4‐aminoquinoline compounds.
24. Treatment of chronic active hepatitis B (CAH B) with chloroquine.
25. Liver changes in porphyria cutanea tarda patients treated with chloroquine.
26. Methotrexate‐associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis.
27. Histopathologic findings in the liver of rheumatoid arthritis patients treated with long‐term bolus methotrexate.
28. Drug‐induced liver disease: an overview.
29. Hepatic ultrastructure after methotrexate therapy for rheumatoid arthritis.
30. Electron microscopic analysis of sequential liver biopsy samples from patients with rheumatoid arthritis: correlation with light microscopic findings.
31. Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients: association with hepatic folate deficiency and formation of polyglutamates.
32. Hepatic parenchymal cell glutamylation of methotrexate studied in monolayer culture.
33. Changes in liver histology during methotrexate therapy of psoriasis correlated to the concentration of methotrexate and folate in erythrocytes.
34. Is? low‐dose pulse methotrexate hepatotoxic in rheumatoid arthritis?
35. Methotrexate kinetics in rheumatoid arthritis: is there an interaction with nonsteroidal antiinflammatory drugs? J?